Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib
IntroductionDogs with allergic dermatitis often suffer concurrent skin and ear infections. The objective of this study was to retrospectively quantify the number of systemic and topical antimicrobial transactions in dogs with allergic dermatitis, following administration of oclacitinib or a glucocor...
Main Authors: | Kennedy Mwacalimba, Andrew Hillier, Michele Rosenbaum, Christopher Brennan, Deborah Amodie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2023.1207582/full |
Similar Items
-
The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
by: Hester Rynhoud, et al.
Published: (2021-02-01) -
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
by: Marike Visser, et al.
Published: (2022-03-01) -
Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma
by: Laura V. Ashton, et al.
Published: (2023-08-01) -
The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study
by: Hester Rynhoud, et al.
Published: (2022-04-01) -
Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
by: Laura E. Barrett, et al.
Published: (2019-08-01)